Tianjin TEDA Biomedical Engineering Company Limited

SEHK:8189 Rapporto sulle azioni

Cap. di mercato: HK$511.5m

Tianjin TEDA Biomedical Engineering Gestione

Gestione criteri di controllo 4/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Li Sun

Amministratore delegato

CN¥620.1k

Compenso totale

Percentuale dello stipendio del CEO75.6%
Mandato del CEO9yrs
Proprietà del CEOn/a
Durata media del management9yrs
Durata media del Consiglio di amministrazione7yrs

Aggiornamenti recenti sulla gestione

Recent updates

There's Reason For Concern Over Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) Massive 73% Price Jump

Oct 17
There's Reason For Concern Over Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) Massive 73% Price Jump

There's Reason For Concern Over Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) Massive 38% Price Jump

Aug 16
There's Reason For Concern Over Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) Massive 38% Price Jump

Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) 26% Share Price Plunge Could Signal Some Risk

May 07
Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) 26% Share Price Plunge Could Signal Some Risk

Is Tianjin TEDA Biomedical Engineering (HKG:8189) Weighed On By Its Debt Load?

Sep 12
Is Tianjin TEDA Biomedical Engineering (HKG:8189) Weighed On By Its Debt Load?

Investors Give Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189) Shares A 28% Hiding

Apr 17
Investors Give Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189) Shares A 28% Hiding

Is Tianjin TEDA Biomedical Engineering (HKG:8189) A Risky Investment?

Apr 07
Is Tianjin TEDA Biomedical Engineering (HKG:8189) A Risky Investment?

Health Check: How Prudently Does Tianjin TEDA Biomedical Engineering (HKG:8189) Use Debt?

Nov 01
Health Check: How Prudently Does Tianjin TEDA Biomedical Engineering (HKG:8189) Use Debt?

Tianjin TEDA Biomedical Engineering (HKG:8189) Is Making Moderate Use Of Debt

Apr 21
Tianjin TEDA Biomedical Engineering (HKG:8189) Is Making Moderate Use Of Debt

Is Tianjin TEDA Biomedical Engineering (HKG:8189) Using Too Much Debt?

Oct 26
Is Tianjin TEDA Biomedical Engineering (HKG:8189) Using Too Much Debt?

Tianjin TEDA Biomedical Engineering (HKG:8189) Has Debt But No Earnings; Should You Worry?

Apr 06
Tianjin TEDA Biomedical Engineering (HKG:8189) Has Debt But No Earnings; Should You Worry?

Health Check: How Prudently Does Tianjin TEDA Biomedical Engineering (HKG:8189) Use Debt?

Dec 22
Health Check: How Prudently Does Tianjin TEDA Biomedical Engineering (HKG:8189) Use Debt?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Li Sun rispetto agli utili di Tianjin TEDA Biomedical Engineering?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

-CN¥7m

Mar 31 2024n/an/a

-CN¥11m

Dec 31 2023CN¥620kCN¥469k

-CN¥15m

Sep 30 2023n/an/a

-CN¥24m

Jun 30 2023n/an/a

-CN¥23m

Mar 31 2023n/an/a

-CN¥28m

Dec 31 2022CN¥709kCN¥571k

-CN¥25m

Sep 30 2022n/an/a

-CN¥66m

Jun 30 2022n/an/a

-CN¥56m

Mar 31 2022n/an/a

-CN¥48m

Dec 31 2021CN¥749kCN¥620k

-CN¥42m

Sep 30 2021n/an/a

-CN¥30m

Jun 30 2021n/an/a

-CN¥42m

Mar 31 2021n/an/a

-CN¥43m

Dec 31 2020CN¥698kCN¥620k

-CN¥48m

Sep 30 2020n/an/a

-CN¥86m

Jun 30 2020n/an/a

-CN¥83m

Mar 31 2020n/an/a

-CN¥87m

Dec 31 2019CN¥728kCN¥620k

-CN¥85m

Sep 30 2019n/an/a

-CN¥133m

Jun 30 2019n/an/a

-CN¥176m

Mar 31 2019n/an/a

-CN¥174m

Dec 31 2018CN¥709kCN¥619k

-CN¥178m

Sep 30 2018n/an/a

-CN¥60m

Jun 30 2018n/an/a

-CN¥16m

Mar 31 2018n/an/a

-CN¥18m

Dec 31 2017CN¥704kCN¥619k

-CN¥14m

Compensazione vs Mercato: La retribuzione totale di Li ($USD 85.61K ) è inferiore alla media delle aziende di dimensioni simili nel mercato Hong Kong ($USD 233.11K ).

Compensazione vs guadagni: La retribuzione di Li è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Li Sun (50 yo)

9yrs

Mandato

CN¥620,127

Compensazione

Ms. Li Sun has been Chairman of the Board and Executive Director of Tianjin TEDA Biomedical Engineering Company Limited since August 20, 2015 and served as Chief Executive Officer since December 30, 2019 u...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Li Sun
Chairman9yrsCN¥620.13kNessun dato
Xin He
Executive Director5.9yrsNessun datoNessun dato
Ka Kuen Ng
Company Secretary18.8yrsCN¥150.00kNessun dato

9.0yrs

Durata media

54yo

Età media

Gestione esperta: Il team dirigenziale di 8189 è esperto e expertise (durata media dell'incarico 9 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Li Sun
Chairman9.3yrsCN¥620.13kNessun dato
Xin He
Executive Director5.9yrsNessun datoNessun dato
Jinyu Liu
Chairman of the Supervisory Committee13.3yrsCN¥124.27kNessun dato
Weitao Liang
Independent Supervisor9.3yrsNessun datoNessun dato
Ximing Li
Non Executive Director7.8yrsCN¥40.00kNessun dato
Chun Gao
Independent Non Executive Director7.8yrsCN¥80.00kNessun dato
Yongkang Wang
Independent Non-Executive Director7yrsCN¥80.00kNessun dato
Aixin Cao
Non-Executive Director7yrsCN¥220.10kNessun dato
Xueying Li
Non-Executive Director3.5yrsNessun datoNessun dato
Zhiyou Zhao
Independent Supervisor2.8yrsNessun datoNessun dato
Xiangzhen Tu
Independent Non-Executive Directorless than a yearNessun datoNessun dato

7.0yrs

Durata media

52.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 8189 sono considerati esperti (durata media dell'incarico 7 anni).